Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Walter Fratta

Showing results (21-30 of 80) with videos related to

Pageof 8
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 27, 2009
Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult ratsMaria Sabrina Spano, Paola Fadda, Roberto Frau, et al.
International Journal of Molecular Sciences|March 6, 2021
Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical ResearchPhilippe A Melas, Maria Scherma, Walter Fratta, et al.
Psychopharmacology|August 21, 2012
Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult ratsMaria Sabrina Spano, Liana Fattore, Francesca Cadeddu, et al.
Current Pharmaceutical Design|July 9, 2013
The role of the endocannabinoid system in eating disorders: neurochemical and behavioural preclinical evidenceMaria Scherma, Liana Fattore, Maria Paola Castelli, et al.
Dialogues in Clinical Neuroscience|November 9, 2020
Cannabinoids and their therapeutic applications in mental disorders
Maria Scherma, Anna Lisa Muntoni, Gernot Riedel, et al.
Behavioural Brain Research|January 13, 2006
Scopolamine and MK801-induced working memory deficits in rats are not reversed by CBD-rich cannabis extractsPaola Fadda, Lianne Robinson, Walter Fratta, et al.
The European Journal of Neuroscience|April 11, 2007
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2Liana Fattore, Daniela Viganò, Paola Fadda, et al.
Acta Pharmacologica Sinica|July 28, 2018
Brain activity of anandamide: a rewarding bliss?Maria Scherma, Paolo Masia, Valentina Satta, et al.
Frontiers in Behavioral Neuroscience|November 15, 2018
Sex and Feeding Status Differently Affect Natural Reward Seeking Behavior in Olfactory Bulbectomized RatsJana Ruda-Kucerova, Mary Tresa Zanda, Petra Amchova, et al.
Medicines (Basel, Switzerland)|October 4, 2018
New Perspectives on the Use of Cannabis in the Treatment of Psychiatric DisordersMaria Scherma, Paolo Masia, Matteo Deidda, et al.
Pageof 8

Showing results (21-30 of 80) with videos related to

Sort By:
Pageof 8
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|October 27, 2009
Cannabinoid self-administration attenuates PCP-induced schizophrenia-like symptoms in adult ratsMaria Sabrina Spano, Paola Fadda, Roberto Frau, et al.
International Journal of Molecular Sciences|March 6, 2021
Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical ResearchPhilippe A Melas, Maria Scherma, Walter Fratta, et al.
Psychopharmacology|August 21, 2012
Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult ratsMaria Sabrina Spano, Liana Fattore, Francesca Cadeddu, et al.
Current Pharmaceutical Design|July 9, 2013
The role of the endocannabinoid system in eating disorders: neurochemical and behavioural preclinical evidenceMaria Scherma, Liana Fattore, Maria Paola Castelli, et al.
Dialogues in Clinical Neuroscience|November 9, 2020
Cannabinoids and their therapeutic applications in mental disorders
Maria Scherma, Anna Lisa Muntoni, Gernot Riedel, et al.
Behavioural Brain Research|January 13, 2006
Scopolamine and MK801-induced working memory deficits in rats are not reversed by CBD-rich cannabis extractsPaola Fadda, Lianne Robinson, Walter Fratta, et al.
The European Journal of Neuroscience|April 11, 2007
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2Liana Fattore, Daniela Viganò, Paola Fadda, et al.
Acta Pharmacologica Sinica|July 28, 2018
Brain activity of anandamide: a rewarding bliss?Maria Scherma, Paolo Masia, Valentina Satta, et al.
Frontiers in Behavioral Neuroscience|November 15, 2018
Sex and Feeding Status Differently Affect Natural Reward Seeking Behavior in Olfactory Bulbectomized RatsJana Ruda-Kucerova, Mary Tresa Zanda, Petra Amchova, et al.
Medicines (Basel, Switzerland)|October 4, 2018
New Perspectives on the Use of Cannabis in the Treatment of Psychiatric DisordersMaria Scherma, Paolo Masia, Matteo Deidda, et al.
Pageof 8